Subcutaneous injection delivers more predictable and consistent dosing
Clinical trial signals exist, and they deserve context: Sleep Recovery, 2024 documents that in a clinical trial, 7% of patients taking Wegovy reported insomnia as a side effect, a finding that suggests a measurable signal in controlled study conditions, yet does not prove causation for everyone taking the drug
This gap between theory and data creates the environment where compounded combinations proliferate without solid scientific foundation
Older adults: standards of care in diabetes-2025
For diabetic patients or people struggling with excess pounds, Ozempic offers clear benefits when combined with lifestyle changes
Semaglutide (the main component in Ozempic) is approved for the treatment of obesity, however, when used for weight control the company that makes it (Novo Nordisk) calls it Wegovy